Search results for "Cardiovascular disease"
EHR alert had small effect on lipid therapy in highest-risk patients
A trial alert nudged clinicians seeing patients with very high-risk atherosclerotic cardiovascular disease to intensify therapy by prescribing a high-intensity statin, adding ezetimibe, or prescribing a proprotein subtilisin/kexin type 9 inhibitor.
https://immattersacp.org/weekly/archives/2024/04/30/4.htm
30 Apr 2024
Considerations about cannabis
As more states legalize recreational and medical cannabis, hospital physicians are finding themselves caring for regular users more frequently.
https://immattersacp.org/archives/2024/05/considerations-about-cannabis.htm
1 May 2024
First NASH treatment, over-the-counter CGM approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/05/first-nash-treatment-over-the-counter-cgm-approved.htm
1 May 2024
Anxiety, depression treatment linked with improved outcomes in cardiovascular disease
Patients who had been hospitalized and had both cardiovascular disease and a mental health condition were 75% less likely to be readmitted if they received psychotherapy and medication for their anxiety or depression.
https://immattersacp.org/weekly/archives/2024/03/26/4.htm
26 Mar 2024
Statins underused in patients with cardiovascular disease, study finds
Women, older adults, and those with peripheral artery disease and cerebrovascular disease are particularly likely not to receive statins, according to an industry-funded analysis of lipid-lowering therapy use.
https://immattersacp.org/weekly/archives/2023/08/08/2.htm
8 Aug 2023
New 'weighs' to treat obesity
Even as the data on weight loss drugs mount, physicians need to help patients navigate potentially prohibitive costs and a continuing need for lifestyle change.
https://immattersacp.org/archives/2024/03/new-weighs-to-treat-obesity.htm
1 Mar 2024
Salt substitution associated with lower mortality
A systematic review and meta-analysis found that salt substitutes may be associated with lower risk for all-cause and cardiovascular mortality but noted that most of the evidence is from older populations and those eating an Asian diet.
https://immattersacp.org/weekly/archives/2024/04/09/1.htm
9 Apr 2024
Subclinical eGFR associated with cardiovascular disease in younger patients
A retrospective cohort study in Canada found that the relative risk for major cardiovascular events with or without heart failure increased in adults ages 18 to 39 years with an eGFR below 80 mL/min/1.73 m2.
https://immattersacp.org/weekly/archives/2023/09/19/2.htm
19 Sep 2023
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/04/latest-updates-on-acps-priorities-initiatives.htm
1 Apr 2024
Recommendations released on statin therapy for people with HIV
The guidance from a panel of the U.S. Department of Health and Human Services addresses primary prevention of atherosclerotic cardiovascular disease in patients ages 40 to 75 years and younger than age 40 years.
https://immattersacp.org/weekly/archives/2024/03/05/2.htm
5 Mar 2024